Clinical Trial Update: Infrapopliteal Drug Eluting Angioplasty Versus Stenting [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2/3 trial comparing infrapopliteal drug-eluting angioplasty to stenting in patients with peripheral artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Snippet

Sponsor: University of Patras | Conditions: Arterial Occlusive Disease | Phase 2, Phase 3 | Status: COMPLETED